Literature DB >> 11722276

Initiating antiretroviral therapy during HIV infection: confusion and clarity.

R J Pomerantz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11722276     DOI： 10.1001/jama.286.20.2597

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Population-based hematologic and immunologic reference values for a healthy Ugandan population.

Authors:  Eric S Lugada; Jonathan Mermin; Frank Kaharuza; Elling Ulvestad; Willy Were; Nina Langeland; Birgitta Asjo; Sam Malamba; Robert Downing
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.

Authors:  Thomas M Lampinen; Keith Chan; Robert S Remis; Maraki Fikre Merid; Melanie Rusch; Jean Vincelette; Ken Logue; Vladimir Popovic; Michel Alary; Martin T Schechter; Robert S Hogg
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

3.  Comparing results from multiple imputation and dynamic marginal structural models for estimating when to start antiretroviral therapy.

Authors:  Bryan E Shepherd; Qi Liu; Nathaniel Mercaldo; Cathy A Jenkins; Bryan Lau; Stephen R Cole; Michael S Saag; Timothy R Sterling
Journal:  Stat Med       Date:  2016-06-06       Impact factor: 2.373

Review 4.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Authors:  Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole
Journal:  Lancet       Date:  2009-04-08       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.